Shaperon

Shaperon Financial Leverage

The Financial Leverage (Equity Multiplier) of Shaperon (378800.KQ) as of Oct 15, 2026 is 1.13. In the previous year, Financial Leverage (Equity Multiplier) was 1.21 — a change of -6.53% (lower).

Financial Leverage

1.13

YoY

-6.53%

Last updated:

Financial Leverage (Equity Multiplier) of Shaperon is 2025 1.13 . Financial Leverage (Equity Multiplier) of Shaperon was 2024 1.21 . It decreases by -6.53% lower compared to the previous year.

The Shaperon Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
-0.42 KRW
Jan 1, 2020
-0.59 KRW
Jan 1, 2021
1.11 KRW
Jan 1, 2022
1.20 KRW
Jan 1, 2023
1.32 KRW
Jan 1, 2024
1.21 KRW
Jan 1, 2025
1.13 KRW
The Shaperon Financial Leverage history
YEARFinancial LeverageYoY
1.13-6.53%
1.21-8.45%
1.32+9.66%
1.20+8.39%
1.11-286.19%
-0.59+40.43%
-0.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shaperon Stock analysis

What does Shaperon do? Shaperon Inc is a biotechnology company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the development of pharmaceutical products targeting conditions such as atopic dermatitis, septicemia, and Alzheimer's disease. Shaperon Inc. has a workforce of 40 full-time employees. The company completed its initial public offering (IPO) on October 19, 2022, and is listed under the ticker symbol 378800.KQ with ISIN KR7378800007. Its website is http://shaperon.com/. Shaperon Inc. is engaged in research, development, manufacturing, and commercialization of therapeutic solutions for pneumonia, Alzheimer's disease, and atopic conditions, among other medicines. The company's headquarters are located in Seoul, South Korea. Shaperon Inc. operates as a publicly traded entity following its IPO in 2022, with a focus on advancing treatments for complex medical conditions through biotechnology innovation. Shaperon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shaperon stock

Financial Leverage (Equity Multiplier) of Shaperon is 1.13 in 2025.

Financial Leverage (Equity Multiplier) of Shaperon changed from 1.21 to 1.13, representing a -6.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Shaperon since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Shaperon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Shaperon

All Key Metrics — Shaperon